A lot of attention was garnered by an article which I published on June 1 titled 'A Theory Behind FDA Approval Delays'. The article, linked and reprinted on discussion boards as far away as Germany, gave investors a new point of view from which to contemplate the matter of FDA drug approval delays and it redirected discussions along new paths never before considered.

After reading the article, which was reprinted at WallStreet-Online in Germany, one investor proudly contributed on beha... Read More

0 comments View Entry

One investor and member of the NVestorz.com community wrote, in regards to the upcoming reverse split vote for Genta, Inc. (OTC:GNTA) - "What are the possibilities for after the vote? I’ve haven’t seen what happens after a reverse stock split. I read that it doesn’t treat the stockholder very well."

There can be only two answers to the reverse split decision:

Vote 'No' and the company has threatened that it "may" have to file for bankruptcy. This isn't good for any of the... Read More

0 comments View Entry